Start Date
January 31, 2011
Nilotinib
400 mg by mouth twice a day for 7 days. Patients on Arm 2 will continue to receive Nilotinib until they have disease progression or are resectable.
Collaborators (1)
Novartis
INDUSTRY
M.D. Anderson Cancer Center
OTHER